Originally posted by the Voice of America.
Voice of America content is produced by the Voice of America,
a United States federal government-sponsored entity, and is in
the public domain.


Brazil Suspends Trials of COVID-19 Vaccine in its Final Trials Before
Possible Approval

VOA News

   Brazil's health regulatorAnvisasuspended clinical trials of a Chinese
   firm'scoronavirusvaccine after anunspecified "adverse incident"
   involving a volunteer recipient late last month.

   Anvisawould only saysuch incidentscould involve a death or serious
   disability resulting in hospitalization.

   Anvisa'sactionwith theCoronaVacvaccineoccurredthe same daya
   rival,U.S.pharmaceuticalcompany,Pfizer,announcedits vaccinehas shown90
   percent effectiveness.

   Word of Pfizer'svaccine success sentglobalfinancialmarkets soaring.

   Both the Pfizer andthe ChineseSinovacvaccineare in Phase III trials,
   thelaststage of testing beforeregulators give it clearance for public
   use.

   Brazil has the highest coronavirus tally in Latin America, withmore
   than 5,664,000 confirmed cases and 162,397 deaths, according to
   theJohnsHopkins Universityand Medicine CoronavirusResourceCenter.

.